Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul F Pinsky

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
Gynecologic Oncology|September 13, 2020
Aspirin use and ovarian cancer risk using extended follow-up of the PLCO Cancer Screening TrialLauren M Hurwitz, Paul F Pinsky, Wen-Yi Huang, et al.
Annals of Internal Medicine|September 10, 2014
National Lung Screening Trial findings by age: Medicare-eligible versus under-65 populationPaul F Pinsky, David S Gierada, William Hocking, et al.
The Prostate|April 19, 2018
Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening TrialEric A Miller, Paul F Pinsky, Amanda Black, et al.
BJU International|October 6, 2018
Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trialPaul F Pinsky, Eric Miller, Philip Prorok, et al.
Radiology. Imaging Cancer|April 18, 2020
Low-Dose CT Screening for Lung Cancer: Evidence from 2 Decades of StudyDavid S Gierada, William C Black, Caroline Chiles, et al.
Journal of the National Cancer Institute|September 13, 2024
Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screeningHormuzd A Katki, Philip C Prorok, Philip E Castle, et al.
Clinical Trials (London, England)|June 24, 2010
Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialPaul F Pinsky, Amanda Blacka, Barnett S Kramer, et al.
The Lancet. Gastroenterology & Hepatology|December 4, 2018
Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trialEric A Miller, Paul F Pinsky, Robert E Schoen, et al.
Journal of the National Cancer Institute|September 19, 2025
Contrasts in colorectal cancer incidence and mortality in screening trials of sigmoidoscopy vs the Nordic-European Initiative on Colorectal Cancer colonoscopy trialReinier G S Meester, Eric A Miller, Paul F Pinsky, et al.
Journal of the National Cancer Institute|April 11, 2024
Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screeningHormuzd A Katki, Philip C Prorok, Philip E Castle, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Gynecologic Oncology|September 13, 2020
Aspirin use and ovarian cancer risk using extended follow-up of the PLCO Cancer Screening TrialLauren M Hurwitz, Paul F Pinsky, Wen-Yi Huang, et al.
Annals of Internal Medicine|September 10, 2014
National Lung Screening Trial findings by age: Medicare-eligible versus under-65 populationPaul F Pinsky, David S Gierada, William Hocking, et al.
The Prostate|April 19, 2018
Secondary prostate cancer screening outcomes by race in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Screening TrialEric A Miller, Paul F Pinsky, Amanda Black, et al.
BJU International|October 6, 2018
Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trialPaul F Pinsky, Eric Miller, Philip Prorok, et al.
Radiology. Imaging Cancer|April 18, 2020
Low-Dose CT Screening for Lung Cancer: Evidence from 2 Decades of StudyDavid S Gierada, William C Black, Caroline Chiles, et al.
Journal of the National Cancer Institute|September 13, 2024
Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screeningHormuzd A Katki, Philip C Prorok, Philip E Castle, et al.
Clinical Trials (London, England)|June 24, 2010
Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialPaul F Pinsky, Amanda Blacka, Barnett S Kramer, et al.
The Lancet. Gastroenterology & Hepatology|December 4, 2018
Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trialEric A Miller, Paul F Pinsky, Robert E Schoen, et al.
Journal of the National Cancer Institute|September 19, 2025
Contrasts in colorectal cancer incidence and mortality in screening trials of sigmoidoscopy vs the Nordic-European Initiative on Colorectal Cancer colonoscopy trialReinier G S Meester, Eric A Miller, Paul F Pinsky, et al.
Journal of the National Cancer Institute|April 11, 2024
Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screeningHormuzd A Katki, Philip C Prorok, Philip E Castle, et al.
Pageof 17